Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending June 29, 2025: USD 23.03 B

Johnson & Johnson Operating Cash Flow is USD 23.03 B for the Trailing 12 Months (TTM) ending June 29, 2025, a -6.55% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 24.64 B, a 29.20% change year over year.
  • Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending July 02, 2023 was USD 19.07 B, a -19.12% change year over year.
  • Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending July 03, 2022 was USD 23.58 B, a -9.70% change year over year.
  • Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending July 04, 2021 was USD 26.11 B, a 25.94% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities